Vaccine-associated paralytic poliomyelitis in a patient with MHC class II deficiency

Journal of Clinical Virology

Volumn 39, Issue 2, 2007, Pages 145-148

  Parvaneh, Nima ^a   Shahmahmoudi, Shohreh ^b   Tabatabai, Hamideh ^b   Zahraei, Mohsen ^c   Mousavi, Taha ^c   Esteghamati, Abdol Reza ^c   Gooya, Mohammad M ^c   Mamishi, Setareh ^a   Nategh, Rakhshandeh ^b   Kew, Olen M ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Institute of Public Health Research   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Major histocompatibility class II deficiency; Vaccine associated paralytic poliomyelitis

Indexed keywords

COTRIMOXAZOLE; IMMUNOGLOBULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; ORAL POLIOMYELITIS VACCINE;

ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; IMMUNE DEFICIENCY; INFANT; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II DEFICIENCY; PARALYSIS; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; VACCINE ASSOCIATED PARALYTIC POLIOMYELITIS; VIRUS ISOLATION;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FATAL OUTCOME; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; MALE; POLIOMYELITIS; POLIOVIRUS VACCINE, ORAL; POLYMERASE CHAIN REACTION;

EID: 34248656213     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.04.002     Document Type: Article

References (15)

1. Abo W., Chiba S., Yamanaka T., Nakao T., Hara M., and Tagaya I. Paralytic poliomyelitis in a child with agammaglobulinemia. Eur J Pediatr 132 (1979) 11-16
2. Alexander Jr. J.P., Gary Jr. H.E., and Pallansch M.A. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis 175 Suppl 1 (1997) S176-S182
3. Centers for Disease Control and Prevention. Paralytic poliomyelitis, United States, 1980-1994. MMWR Morb Mortal Wkly Rep 46 (1997) 79-83
4. Davis L.E., Bodian D., Price D., Butler I.J., and Vickers J.H. Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. N Engl J Med 297 (1977) 241-245
5. Guillot S., Otelea D., Delpeyroux F., and Crainic R. Point mutations involved in the attenuation/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by site-specific polymerase chain reaction. Vaccine 12 (1994) 503-507
6. Guillot S., Caro V., Cuervo N., Korotkova E., Combiescu M., Persu A., et al. Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol 74 (2000) 8434-8443
7. Halsey N.A., Pinto J., Espinosa-Rosales F., Faure-Fontenla M.A., da S.E., Khan A.J., et al. Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom. Bull World Health Organ 82 (2004) 3-8
8. Kew O.M., Sutter R.W., de Gourville E.M., Dowdle W.R., and Pallansch M.A. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59 (2005) 587-635
9. Nkowane B.M., Wassilak S.G., Orenstein W.A., Bart K.J., Schonberger L.B., Hinman A.R., et al. Vaccine-associated paralytic poliomyelitis United States: 1973 through 1984. JAMA 257 (1987) 1335-1340
10. Rezaei N., Aghamohammadi A., Moin M., Pourpak Z., Movahedi M., Gharagozlou M., et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol 26 6 (2006) 519-532
11. Villard J., Masternak K., Lisowska-Grospierre B., Fischer A., and Reith W. MHC class II deficiency: a disease of gene regulation. Medicine (Baltimore) 80 (2001) 405-418
12. World Health Organization. Manual of the virological investigation of poliomyelitis. WHO document WHO/EPI/GEN/97.01; 1997.
13. World Health Organization. Inactivated poliovirus vaccine following oral poliovirus vaccine cessation. Wkly Epidemiol Rec 81 (2006) 137-144
14. World Health Organization. Update on vaccine-derived polioviruses. MMWR Morb Mortal Wkly Rep 55 (2006) 1093-1097
15. Wright P.F., Hatch M.H., Kasselberg A.G., Lowry S.P., Wadlington W.B., and Karzon D.T. Vaccine-associated poliomyelitis in a child with sex-linked agammaglobulinemia. J Pediatr 91 (1977) 408-412